BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 11040184)

  • 1. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
    Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
    Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
    Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
    J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.
    Katchar K; Kelly CP; Keates S; O'brien MJ; Keates AC
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1263-71. PubMed ID: 17272517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Sato T; Yamazaki M; Okamoto S; Ishii H; Totsuka T; Iiyama R; Okamoto R; Ikeda M; Kurimoto M; Takeda K; Akira S; Hibi T
    Gastroenterology; 2001 Oct; 121(4):875-88. PubMed ID: 11606501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
    Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
    J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
    Yang X; Meng S; Jiang H; Chen T; Wu W
    Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-associated virus carrying thymosin β
    Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
    World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice.
    Zhao HM; Huang XY; Zuo ZQ; Pan QH; Ao MY; Zhou F; Liu HN; Liu ZY; Liu DY
    World J Gastroenterol; 2013 Feb; 19(5):742-9. PubMed ID: 23430765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
    Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
    Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jα33+ MAIT cells play a protective role in TNBS induced intestinal inflammation.
    Ruijing X; Mengjun W; Xiaoling Z; Shu P; Mei W; Yingcheng Z; Yuling H; Jinquan T
    Hepatogastroenterology; 2012 May; 59(115):762-7. PubMed ID: 22115767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Li J; Liu L; Zhao Q; Chen M
    Dig Dis Sci; 2020 Jul; 65(7):1971-1979. PubMed ID: 31808003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from TNBS-induced colitis leads to the resistance to recurrent colitis and an increased ratio of FOXP3 to CD3 mRNA.
    Chen DF; Lu LG; Tao KZ; Lu ZJ; Yuan YZ
    J Dig Dis; 2013 Nov; 14(11):587-95. PubMed ID: 23786412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.
    Palmen MJ; Wijburg OL; Kunst IH; Kroes H; van Rees EP
    Clin Exp Immunol; 1998 May; 112(2):216-25. PubMed ID: 9649183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.